1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Pharmaceutical Intermediates Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Pharmaceutical Intermediates Market Regional Analysis
6.2 Asia Pacific Pharmaceutical Intermediates Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Pharmaceutical Intermediates Market Forecast Analysis
7. Asia Pacific Pharmaceutical Intermediates Market Analysis – by Type
7.1 GMP
- 7.1.1 Overview
- 7.1.2 GMP: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Non GMP
- 7.2.1 Overview
- 7.2.2 Non GMP: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Pharmaceutical Intermediates Market Analysis – by Application
8.1 Antibiotics
- 8.1.1 Overview
- 8.1.2 Antibiotics: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Antipyretic Analgesics
- 8.2.1 Overview
- 8.2.2 Antipyretic Analgesics: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Vitamins
- 8.3.1 Overview
- 8.3.2 Vitamins: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Pharmaceutical Intermediates Market Analysis – by Distribution Channel
9.1 Distributor
- 9.1.1 Overview
- 9.1.2 Distributor: Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Direct Sales
- 9.2.1 Overview
- 9.2.2 Direct Sales : Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Asia Pacific Pharmaceutical Intermediates Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific
- 10.2.1 Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Asia Pacific Pharmaceutical Intermediates Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 China:
Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.1.2 China: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.1.3 China: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.2 India:
Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.2.2 India: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.2.3 India: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.3 Japan:
Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.3.2 Japan: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.3.3 Japan: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.4 Australia:
Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.4.2 Australia: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.4.3 Australia: Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.5 Rest of Asia-Pacific :
Asia Pacific Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BASF SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 chiracon GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Codexis
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Dextra Laboratories Limited
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Dishman Carbogen Amcis Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Midas Pharma GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Sanofi
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations